T cell lymphocytes play a vital role in adoptive cell therapy for the treatment of chronic viral infections and malignant diseases. In the development of cell-based therapy products, large quantities of high-quality T cells are required, and are often cultured in stirred-tank bioreactors. This application note shows the results of a study that tested the suitability of BioBLU® 0.3c Single-Use Bioreactors controlled by a DASbox Mini Bioreactor System in the long-term expansion of CD4+ T cells as well as the impact of different oxygen tensions on cell proliferation. Download now to learn more.
Please check the highlighted fields and try again.
Please enter your first and last name.
Please enter the name of the company or institution you work at.
Please enter your mailing address.
Please enter the e-mail address you would like to be contacted at.